{"id":4252,"date":"2016-06-13T10:30:00","date_gmt":"2016-06-13T14:30:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/buse-liraglutide\/"},"modified":"2023-06-06T17:10:21","modified_gmt":"2023-06-06T21:10:21","slug":"buse-liraglutide","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/buse-liraglutide\/","title":{"rendered":"Diabetes drug lowers risk of cardiovascular complications, kidney disease"},"content":{"rendered":"
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug \u2013 liraglutide \u2013 a much-needed outcome for people with type 2 diabetes.<\/p>\n
<\/p>\n
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug \u2013 liraglutide \u2013 a much-needed outcome for people with type 2 diabetes.<\/p>\n","protected":false},"author":18672,"featured_media":4253,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[69],"class_list":["post-4252","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-69","odd"],"acf":[],"yoast_head":"\n